Zdrowie i gospodarka · 08/02/2005

FDA to Hold Public Hearing on Adverse Events Reporting to IRBs

The Food and Drug Administration (FDA) is hosting a public hearing to gather feedback on the process of reporting adverse events to institutional review boards (IRBs), with the goal of improving the efficiency and effectiveness of this process in protecting human subjects in clinical studies.